In the United States, there are about 3.4 million people with epilepsy nationwide: 3 million adults and 470,000 children, 1.2% of the total population1. Epilepsy, a disorder of the brain that causes seizures, can affect people in very different ways.
Join Siemens Healthineers and Dr. Laura Bechtel, PhD, DABCC, on May 24th, 2023, at 2:00 PM EDT for our webinar on the importance of therapeutic drug monitoring for epilepsy with examples of real case studies from patients.
After attending this webinar, participants will:
- Understand the etiology and epidemiology of epilepsy, i.e., what is epilepsy and what is it not
- Recognize the importance for epilepsy classification
- Know the medications for treating epilepsy along with the latest guidelines around monitoring using clinical diagnostic lab assays
Speaker
Dr. Laura Bechtel, PhD, DABCC
Senior Clinical Consultant, Siemens Healthineers
Laura Bechtel is a DABCC certified Clinical Chemist and completed her training at the University of Virginia. She has a PhD in Pharmacology and Toxicology and a M.S./B.S. in Microbiology. Dr. Bechtel has previous experience as a Section Director, Lab Director, and Technical Director at Memorial Sloan Kettering, University of Colorado Anschutz, Cordant, and Kaiser Permanente. She recently joined Siemens Healthineers as a Medical Affairs Strategy Consultant to support laboratorians and clinicians with utilization of test methodologies focused on improving patient care.
